Literature DB >> 3850770

Management of cardioinhibitory hypersensitive carotid sinus syncope with permanent cardiac pacing--a seventeen year prospective study.

D I Peretz, A Abdulla.   

Abstract

Sudden and unannounced syncope due to increased vagal tone as manifested by hypersensitivity of the carotid sinus mechanism is not uncommon. A 17 year prospective study of 89 patients with cardio-inhibitory (Type 1) hypersensitivity showed that males outnumbered females 4.5:1. The age range at the onset of symptoms was 37 to 88 years with an average of 63 years. Hypersensitivity of the right carotid sinus was 7:1 compared to the left. These patients had unilateral hypersensitivity in 71% and bilateral in 29%. A new classification of Hypersensitive Carotid Sinus Syncope incorporating sinoatrial node (Type 1A) and atriaoventricular node (Type 1B) suppression in the Type 1 syndrome is presented. Many forms of treatment for cardioinhibitory Hypersensitive Carotid Sinus Syncope have been forthcoming but in our hands in these 89 patients over 17 years, there has been no single case of recurrence of syncope after implantation of a permanent VVI electronic cardiac pacemaker. Type 2 (vasodepressor) Hypersensitive Carotid Sinus Syncope is rare, occasionally seen combined with the cardioinhibitory (Type 1) response and it is not helped with cardiac pacing.

Entities:  

Mesh:

Year:  1985        PMID: 3850770

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  3 in total

Review 1.  The sympathetic nervous system and baroreflexes in hypertension and hypotension.

Authors:  J L Izzo; A A Taylor
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

Review 2.  The management of patients with carotid sinus syndrome: is pacing the answer?

Authors:  Jeff Healey; Stuart J Connolly; Carlos A Morillo
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

3.  Long-Term Mortality in Cardioinhibitory Carotid Sinus Hypersensitivity Patient Cohort.

Authors:  Gustavo de Castro Lacerda; Andrea Rocha de Lorenzo; Bernardo Rangel Tura; Marcela Cedenilla Dos Santos; Artur Eduardo Cotrim Guimarães; Renato Côrtes de Lacerda; Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.